Sort   by:  
 Page size 
ProteomicsProteomic effects of lysergic acid diethylamide in iPSC-derived brain organoids
Lysergic acid diethylamide (LSD), considered the prototypical psychedelic molecule, has effects on consciousness and perception. However, the molecular mechanisms involved in LSD effects in human neural cells and how they may be translated into changes in physiology are still poorly understood. Here...
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD027369 | Pride
Lsd Cerebral organoid Neural cell Ips Proteome 
ProteomicsSignaling mechanisms of the prototypical psychedelic LSD
Serotonin (5-hydroxytryptamine; 5-HT) 5-HT2-family receptors are the key targets of the prototypical psychedelic LSD. Although the canonical signaling pathway for 5-HT2 receptors is mediated by Gq protein, recent studies suggest that G-protein independent signaling, namely β-arrestin signaling pathw...
ORGANISM(S): Homo sapiens (Human) 
2023-10-24 | PXD030752 | Pride
Lc-msms 
ProteomicsnMOST to analyze proteome and lipidome of LSD mutant cells
This data set contains nano flow multi-omics single shot technology (nMOST) data collected from a collection of LSD mutant cell lines. Pilot data for nMOST method development is also included.
ORGANISM(S): Saccharomyces Cerevisiae (ncbitaxon:4932) Homo Sapiens (ncbitaxon:9606) Mus Musculus (ncbitaxon:10090) Caenorhabditis Elegans (ncbitaxon:6239) 
2024-02-28 | MSV000094201 | MassIVE
ProteomicsLysergic acid dethylamide proteomics modulation in brain organoids
Lysergic acid diethylamide (LSD), considered the prototypical psychedelic molecule, has effects on consciousness and perception. However, the molecular mechanisms involved in LSD effects in human neural cells and how they may be translated into changes in physiology are still poorly understood. Here...
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD037814 | Pride
Cerebral organoid Ipsc Neural cell Proteome 
GenomicsChronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia [RNA-seq]
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia [RNA-seq]
PRJNA743513 | ENA
UnknownAnalytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).
Not available
S-EPMC12319525 | biostudies-literature
TranscriptomicsChronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia [RNA-seq]
Chronic administration of lysergic acid diethylamide (LSD) every other day to rats results in a variety of abnormal behaviors. These build over the 90 day course of treatment and can persist at full strength for at least several months after cessation of treatment. The behaviors are consistent with ...
ORGANISM(S): Rattus norvegicus 
2021-11-11 | GSE179379 | GEO
Genomics
LSD related cancer
PRJNA929903 | ENA
UnknownDevelopment and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
Not available
S-EPMC6817285 | biostudies-literature
UnknownModern Clinical Research on LSD.
Not available
S-EPMC5603820 | biostudies-literature
Sort   by:  
 Page size